Clinical trial
Novel Pharmacotherapy for Dual Dependence
NCT00448825 · Bankole Johnson, Other · Unknown status
Key facts
| NCT number | NCT00448825 |
|---|---|
| Title | Novel Pharmacotherapy for Dual Dependence |
| Official title | Novel Pharmacotherapy for Dual Dependence |
| Lead sponsor | Bankole Johnson, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alcohol Dependence, Cocaine Dependence |
| Intervention type | Drug |
| Interventions | Topiramate + Cognitive Behavioral Therapy, Placebo + Cognitive Behavioral Therapy |
| Enrollment | 180 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Mar 19, 2007 |
| Last update posted | Mar 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: